Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lexaria Bioscience Corp (NQ: LEXX ) 3.090 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Lexaria Bioscience Corp < Previous 1 2 3 4 5 Next > Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 09, 2023 We're starting off the day with the biggest pre-market stock movers traders will want to keep in mind while trading on Tuesday! Via InvestorPlace 12 Health Care Stocks Moving In Monday's Intraday Session May 08, 2023 Via Benzinga Lexaria's DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride And Cholesterol Levels March 02, 2023 Lexaria Bioscience Corp.’s (NASDAQ: LEXX) (NASDAQ: LEXXW) diabetes animal model study DIAB-A22-1 has been completed and produced at least three positive outcomes including weight loss in Via Benzinga $1M Bet On Glatfelter? Check Out These 4 Penny Stocks Insiders Are Buying February 28, 2023 The Dow Jones closed lower by over 70 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... Via Benzinga Lexaria Bioscience' Tech Processed Cannabidiol Receives Positive FDA Feedback For Hypertension August 10, 2022 Via Benzinga Lexaria Posied To Receive US Patent For DehydraTECH To Deliver Antiviral Drugs April 21, 2022 Via Benzinga Why Is Lexaria Bioscience (LEXX) Stock Up Today? April 14, 2022 Today, investors in Lexaria Bioscience and LEXX stock are seeing impressive gains as investors price a key catalyst into shares. Via InvestorPlace Lexaria Discovers Potential Novel Mechanism From Hypertension Study Of Processed CBD February 21, 2023 Via Benzinga This BioTech Company Using CBD For Enhanced Hypertension Treatment Could Be One To Watch November 07, 2022 Lexaria Bioscience Corp. Via Benzinga Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary August 10, 2022 Via Benzinga Lexaria Gets FDA's Positive Feedback On Pre-Clinical Trial Of Hypertension Candidate August 10, 2022 Lexaria Bioscience Corp. (NASDAQ: LEXX) announced that it has received a positive full written response from the Food and Drug Administration (FDA) from its pre-Investigational New Drug meeting... Via Benzinga Recap of Wednesday's Biotech Catalysts - End of The Day Summary July 27, 2022 Via Benzinga Why Lexaria Shares Are Rising Today April 14, 2022 Via Benzinga Lexaria's DehydraTECH CBD Hypertension Study Dosing Complete With No Serious Adverse Events July 27, 2022 Lexaria Bioscience Corp. (NASDAQ: LEXX) (NASDAQ: LEXXW) revealed that dosing with Lexaria's DehydraTECH-processed CBD has been completed in its multi-week human clinical hypertension study HYPER-H21-4 Via Benzinga 67 Biggest Movers From Yesterday June 22, 2022 Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital. Via Benzinga Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet June 21, 2022 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 2.5% on Tuesday. Via Benzinga Why Shares Of Lexaria Biosciences Are Trading Higher June 21, 2022 Lexaria Bioscience Corp. (NASDAQ: LEXX) shares are trading higher after the company announced manufacturing and license agreements with BevNology. Via Benzinga Dow Jumps 550 Points; Convey Health Solutions Shares Spike Higher June 21, 2022 U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 550 points on Tuesday. Via Benzinga 45 Stocks Moving In Tuesday's Mid-Day Session June 21, 2022 Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,. Via Benzinga Lexaria Bioscience (NASDAQ: LEXX) Advancing DehydraTECH-Nicotine Research April 26, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Lexaria expects to begin dosing this summer as part of a human... Via Benzinga Lexaria Bioscience (NASDAQ: LEXX) Secures Patent For DehydraTECH To Deliver Antivirals April 22, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga 53 Biggest Movers From Yesterday April 21, 2022 Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum... Via Benzinga Lexaria Bioscience (NASDAQ: LEXX) Commences Its Most Comprehensive Study To Date April 20, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga 28 Stocks Moving In Wednesday's Mid-Day Session April 20, 2022 Gainers Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) climbed 58.3% to $2.2950 after jumping around 22% on Tuesday. AlloVir, Inc. (NASDAQ: ALVR) shares climbed 39% to $7.52... Via Benzinga Lexaria Bioscience (NASDAQ: LEXX) Announces Positive Results From Hypertension Study April 18, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session April 14, 2022 Gainers Via Benzinga 51 Biggest Movers From Thursday April 18, 2022 Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of... Via Benzinga Lexaria Bioscience (NASDAQ: LEXX) Issues Update On Human Nicotine Study April 13, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga Lexaria Bioscience (NASDAQ: LEXX) Begins Nicotine Formulation Creation, Evaluation Program April 12, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga Lexaria Aims To Demonstrate DehydraTECH's Performance In Epilepsy Research April 11, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.